by Hayden Roberts | Mar 7, 2024
The work continues, and we can’t do it without you!
by Hayden Roberts | Mar 7, 2024
Uniting leaders in rare cancer and tissue-agnostic drug development to identify opportunities for cross-company collaboration.
by Hayden Roberts | Mar 7, 2024
A highly interactive, now-annual meeting that promotes collaboration between clinicians, researchers, industry, patient advocates, patients, and others to address the needs of people living with rare cancers.
by Hayden Roberts | Mar 7, 2024
Bringing rare cancer experts together with TCF community members to provide insights and answer questions on a range of rare cancer topics from clinical trial participation to genetic and genomic testing.
by Hayden Roberts | Mar 7, 2024
A cutting-edge precision oncology trial enrolling 400 patients with rare cancers and cancer of unknown primary using a remote consenting process, and providing biomarker testing and expert treatment recommendations.
